EV/EBITDA
-5.46
0.000.00%
62 min ago
Summary
- As of February 22, 2025, KPTI EV/EBITDA is -5.46, unchanged from the previous trading day.
- Over the past year, KPTI EV/EBITDA has dropped by -3.24 (-145.95%).
- KPTI EV/EBITDA is now -387.50% below its all-time high of -1.12.
Performance
KPTI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KPTI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | -0.0% | -0.1% |
| 1 m1 month | +4.0% | -4.0% | -10.1% |
| 3 m3 months | -35.8% | -3.6% | -19.1% |
| 6 m6 months | -60.1% | -0.6% | -22.6% |
| ytdytd | +3.0% | -2.9% | -7.5% |
| 1 y1 year | -145.9% | -19.7% | -47.6% |
| 5 y5 years | +4.9% | -79.9% | -96.1% |
KPTI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.9% | -5.76 | +5.2% | |
| 3 m | 3-month | -3.68 | -48.4% | -6.05 | +9.8% |
| 6 m | 6-month | -3.17 | -72.2% | -6.05 | +9.8% |
| 1 y | 1-year | -2.14 | -155.1% | -6.05 | +9.8% |
| 3 y | 3-year | -1.74 | -213.8% | -11.13 | +50.9% |
| 5 y | 5-year | -1.74 | -213.8% | -11.13 | +50.9% |
| alltime | all time | -1.12 | -387.5% | -33.48 | +83.7% |
Karyopharm Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -5.46(-3.0%) |
| 2024 | -5.63(+199.5%) |
| 2023 | -1.88(-39.2%) |
| 2022 | -3.09(-37.2%) |
| 2021 | -4.92(-30.6%) |
| 2020 | -7.09(+3.8%) |
| Date | Value |
|---|---|
| 2019 | -6.83(+115.5%) |
| 2018 | -3.17(0.0%) |
| 2017 | -3.17(+0.3%) |
| 2016 | -3.16(-10.2%) |
| 2015 | -3.52(-75.2%) |
| 2014 | -14.22(-8.0%) |
| 2013 | -15.45 |
FAQ
- What is Karyopharm Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Karyopharm Therapeutics?
- What is KPTI EV/EBITDA year-to-date change?
- What is Karyopharm Therapeutics EV/EBITDA year-on-year change?
What is Karyopharm Therapeutics EV/EBITDA?
The current EV/EBITDA of KPTI is -5.46
What is the all time high EV/EBITDA for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high EV/EBITDA is -1.12
What is KPTI EV/EBITDA year-to-date change?
Karyopharm Therapeutics EV/EBITDA has changed by +0.17 (+3.02%) since the beginning of the year
What is Karyopharm Therapeutics EV/EBITDA year-on-year change?
Over the past year, KPTI EV/EBITDA has changed by -3.24 (-145.95%)